Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial outer membrane is a unique structural feature of Gram-negative bacteria, characterized by an asymmetric bilayer where the outer leaflet is primarily composed of lipopolysaccharide (LPS) (Raetz & Whitfield, 2002, Annual Review of Biochemistry). Lipid A is the highly conserved, hydrophobic anchor of LPS and serves as the primary mediator of endotoxic activity by triggering the TLR4 signaling pathway in host immune cells (Park & Lee, 2013, Experimental & Molecular Medicine). This structure acts as a formidable permeability barrier, protecting the bacterium from environmental stressors and many classes of antibiotics (Nikaido, 2003, Microbiology and Molecular Biology Reviews). Therapeutically, the outer membrane and Lipid A are targeted by polymyxins, which disrupt membrane integrity through electrostatic interactions with negatively charged phosphate groups (Poirel et al., 2017, Clinical Microbiology Reviews). Emerging therapies also focus on inhibiting the transport machinery, such as the Lpt pathway, that assembles LPS at the cell surface (Sperandeo et al., 2019, BBA - Molecular and Cell Biology of Lipids). Targeting this component is critical for treating multidrug-resistant Gram-negative infections, though it carries risks such as nephrotoxicity and the potential for massive endotoxin release during bacterial lysis (Zavascki et al., 2007, Journal of Antimicrobial Chemotherapy).
Disruption of outer membrane integrity via displacement of divalent cations from Lipid A phosphate groups; inhibition of LPS transport proteins (e.g., LptD).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide and Bacterial Outer Membrane (LPS).